American Journal of Psychiatry· Clotilde GuidettiRiccardo De GiorgiNathan T.M. HunekeFranco De CrescenzoChiara ZippiGeorge I. PapakostasMaurizio Fava1Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston. 2Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. 3Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK. 4Department of Experimental Medicine, University of Salento, Lecce, Italy. 5Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. 6Hampshire and Isle of Wight Healthcare NHS Foundation Trust, Southampton, UK. 7Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany. 8Section of Pharmacology, Department of Healthcare Surveillance and Bioethics, Catholic University Medical School, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome. 9IQVIA, Clinical Operations, Milan, Italy.·· 2026-07-29AI 评分42
重性抑郁障碍随机对照试验中非特异性治疗反应的决定因素：一篇叙述性综述
Determinants of Nonspecific Response to Treatment in Randomized Controlled Trials of Major Depressive Disorder: A Narrative Review
AI 导读
一篇发表于 American Journal of Psychiatry 的叙述性综述梳理了重性抑郁障碍随机对照试验中非特异性治疗反应的决定因素。文章聚焦安慰剂效应、期望、医患关系等非特异性因素如何影响 RCT 中的治疗反应评估。
来源：American Journal of Psychiatry · psychiatryonline.org